A detailed history of Atwood & Palmer Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Atwood & Palmer Inc holds 13,328 shares of BMY stock, worth $783,419. This represents 0.05% of its overall portfolio holdings.

Number of Shares
13,328
Previous 13,328 -0.0%
Holding current value
$783,419
Previous $553,000 24.59%
% of portfolio
0.05%
Previous 0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 10, 2024

BUY
$47.98 - $54.4 $6,045 - $6,854
126 Added 0.95%
13,328 $722,000
Q1 2023

Apr 21, 2023

SELL
$65.71 - $74.53 $19,450 - $22,060
-296 Reduced 2.19%
13,202 $915,000
Q4 2022

Jan 31, 2023

BUY
$68.48 - $81.09 $136 - $162
2 Added 0.01%
13,498 $971,000
Q1 2022

Apr 29, 2022

SELL
$61.48 - $73.72 $20,964 - $25,138
-341 Reduced 2.46%
13,496 $986,000
Q4 2021

Jan 24, 2022

SELL
$53.63 - $62.52 $1,823 - $2,125
-34 Reduced 0.25%
13,837 $863,000
Q3 2021

Oct 19, 2021

BUY
$59.17 - $69.31 $295 - $346
5 Added 0.04%
13,871 $821,000
Q2 2021

Jul 26, 2021

SELL
$61.91 - $67.42 $21,668 - $23,597
-350 Reduced 2.46%
13,866 $927,000
Q1 2021

Apr 26, 2021

BUY
$59.34 - $66.74 $17,802 - $20,022
300 Added 2.16%
14,216 $897,000
Q2 2020

Jul 24, 2020

SELL
$54.82 - $64.09 $1,644 - $1,922
-30 Reduced 0.22%
13,916 $818,000
Q1 2020

Apr 20, 2020

BUY
$46.4 - $67.43 $1,392 - $2,022
30 Added 0.22%
13,946 $777,000
Q4 2019

Feb 05, 2020

BUY
$49.21 - $64.19 $104,325 - $136,082
2,120 Added 17.97%
13,916 $893,000
Q3 2019

Oct 21, 2019

SELL
$42.77 - $50.71 $17,108 - $20,284
-400 Reduced 3.28%
11,796 $598,000
Q3 2018

Oct 29, 2018

SELL
$55.19 - $62.25 $11,038 - $12,450
-200 Reduced 1.61%
12,196 $757,000
Q1 2018

Apr 30, 2018

SELL
$59.92 - $68.98 $13,422 - $15,451
-224 Reduced 1.77%
12,396 $784,000
Q3 2017

Oct 16, 2017

SELL
$55.23 - $63.74 $41,422 - $47,805
-750 Reduced 5.61%
12,620 $804,000
Q2 2017

Aug 08, 2017

BUY
N/A
13,370
13,370 $745,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Atwood & Palmer Inc Portfolio

Follow Atwood & Palmer Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwood & Palmer Inc, based on Form 13F filings with the SEC.

News

Stay updated on Atwood & Palmer Inc with notifications on news.